• ¿Documento equivocado? Cámbialo gratis
  • Escrito por estudiantes que aprobaron
  • Inmediatamente disponible después del pago
  • Leer en línea o como PDF
Vender
¿Dónde estudias?
Tu idioma
Document preview thumbnail
Vista previa 3 fuera de 24 páginas
Examen

NU 578 Pharmacology 2026/2027 – Unit 2 Complete Study Guide with Verified Answers & Rationales

Document preview thumbnail
Vista previa 3 fuera de 24 páginas

This comprehensive study guide is specifically designed for the NU 578 Advanced Pharmacology Unit 2 examination at the University of South Alabama, offering a complete collection of exam-aligned questions and answers for the 2026/2027 academic year. This in-depth resource covers all essential topics assessed in Unit 2, including neuropharmacology, Parkinson's disease pharmacotherapy (dopaminergic agents, anticholinergics, MAO-B inhibitors), opioid pharmacology and pain management, migraine prophylaxis and treatment (beta-blockers, triptans, anticonvulsants), psychiatric pharmacology (antidepressants, antipsychotics, mood stabilizers), substance use disorders, autonomic nervous system drugs, and medication safety considerations. Each question is paired with verified answers and detailed rationales to strengthen clinical reasoning, reinforce pharmacologic principles, and ensure thorough preparation for this critical advanced practice nursing examination . Developed exclusively for graduate-level nursing students, MSN, APRN, and DNP candidates in pharmacology courses, this complete study guide serves as the ultimate tool for comprehensive exam readiness . By engaging with these exam-aligned practice questions and studying the accompanying rationales, students can systematically evaluate their knowledge, pinpoint strengths and weaknesses, and build the confidence necessary to succeed on the Unit 2 examination . This resource is vital for mastering advanced pharmacology concepts and advancing academic and clinical progress in graduate nursing programs . Vertical Keywords NU 578 Unit 2 Study Guide Advanced Pharmacology Exam Prep Neuropharmacology Practice Questions Parkinson's Disease Drug Therapy Opioid Pharmacology Review Psychiatric Pharmacology Drugs APRN Pharmacology Exam Graduate Nursing Pharmacology MAO-B Inhibitors Migraine Treatment Medications Verified NU 578 Answers University of South Alabama Nursing

Vista previa del contenido

UNIVERSITY OF SOUTH ALABAMA — COLLEGE OF NURSING




NU 578 Pharmacology
Unit 2 Complete Study
Guide
All 179 Practice Questions with Detailed Rationales



Topic Focus: Opioids, CNS Stimulants, Sedative-Hypnotics, Antidepressants,
Antiepileptics, Parkinson's, MS, Alzheimer's


Edition 1 · August 2026 · 179 Questions




Table of Contents

1. Instructions for Use 2

2. Opioids (Questions 1–25) 2

3. CNS Stimulants (Questions 26–40) 4

4. Sedative-Hypnotics & Antianxiety (Questions 41–60) 5

,5. Antidepressants (Questions 61–90) 7

6. Lithium & Local Anesthetics (Questions 91–105) 9

7. Parkinson's Disease (Questions 106–130) 10

8. Alzheimer's Disease (Questions 131–145) 12

9. Multiple Sclerosis (Questions 146–160) 13

10. Antiepileptic Drugs (Questions 161–179) 14


NU 578 Pharmacology Page 1

, NU 578 PHARMACOLOGY STUDY GUIDE OPIOIDS — Q1–25




How to Use This Guide
Read each stem, choose your answer, then check the rationale directly below it. The correct
option is marked, and each wrong option is explained so you understand why it's wrong — not
just that it is. All 179 questions are derived directly from the source material and verified for
accuracy.



Category: Opioids — Questions 1–25


1 What is the mechanism of action (MOA) of opioid drugs?

A Bind to opiate receptors in the brain, disrupting transmission of pain signals in the
CNS; mimic actions of endogenous opiates (endorphins, enkephalins, dynorphins);
primarily activate mu receptors
B Block the reuptake of serotonin and norepinephrine
C Inhibit the breakdown of GABA
D Activate dopamine receptors in the limbic system


Why A is correct: Opioids bind to opiate receptors (primarily mu, but also kappa) in the
brain, disrupting pain signal transmission. They mimic endogenous opioids (endorphins,
enkephalins, dynorphins).

B — This describes the action of SNRIs or TCAs.
C — This describes benzodiazepine action.
D — This describes stimulant action.

Información del documento

Subido en
4 de agosto de 2026
Número de páginas
24
Escrito en
2026/2027
Tipo
Examen
Contiene
Preguntas y respuestas
$12.99

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Seller avatar
Los indicadores de reputación están sujetos a la cantidad de artículos vendidos por una tarifa y las reseñas que ha recibido por esos documentos. Hay tres niveles: Bronce, Plata y Oro. Cuanto mayor reputación, más podrás confiar en la calidad del trabajo del vendedor.
DrEmma
4.2
(9)
Vendido
70
Seguidores
2
Artículos
1567
Última venta
1 día hace



Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes